US FDA Ends 2019 With Second-Highest Approval Count After Second-Half Rebound

 
• By Michael Cipriano
  
Pink Sheet Perspectives 2019 to 2020
CDER Approved 48 novel agents in 2019, the second highest total of the contemporary FDA.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approvals

More from Product Reviews